Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2737]

Damage to gut bacteria linked with chemo-induced weight gain in breast cancer patients

Damage to gut bacteria linked with chemo-induced weight gain in breast cancer patients

Overweight BMI linked to better outcomes in patients with head & neck cancer

Overweight BMI linked to better outcomes in patients with head & neck cancer

The benefits of anti-CD69 antibodies for future cancer therapies

The benefits of anti-CD69 antibodies for future cancer therapies

Bowel cancer: Researchers find possible cause for chemoresistance

Bowel cancer: Researchers find possible cause for chemoresistance

$Patients with refractory metastatic colorectal cancer experience survival benefits with fruquintinib$

Patients with refractory metastatic colorectal cancer experience survival benefits with fruquintinib

EHA 2023: Selinexor subgroup data from the BOSTON trial highlights its clinical potential in R/R Multiple Myeloma

EHA 2023: Selinexor subgroup data from the BOSTON trial highlights its clinical potential in R/R Multiple Myeloma

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

ASCO 2023: Radiotherapy may not be necessary after chemoimmunotherapy for primary mediastinal B-cell lymphoma

ASCO 2023: Radiotherapy may not be necessary after chemoimmunotherapy for primary mediastinal B-cell lymphoma

ASCO 2023: Phase 3 trial demonstrates one-year PFS in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy

ASCO 2023: Phase 3 trial demonstrates one-year PFS in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma...

ASCO 2023: Results of SWOG S1929 trial show small-cell lung cancer patients with SLFN11 expression can benefit from PARP inhibitor added to immune checkpoint blockade

ASCO 2023: Results of SWOG S1929 trial show small-cell lung cancer patients with SLFN11 expression can benefit...

More from ecancer